Open AccessEndoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer
Author(s) -
Reiko Ashida,
Nobuyasu Fukutake,
Ryoji Takada,
Tatsuya Ioka,
Kazuyoshi Ohkawa,
Kazuhiro Katayama,
Hirofumi Akita,
Hidenori Takahashi,
Shingo Ohira,
Teruki Teshima
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i7.768
Subject(s) - fiducial marker , medicine , endoscopic ultrasound , pancreatic cancer , radiology , gold standard (test) , tumor marker , radiation therapy , prospective cohort study , cancer , nuclear medicine , surgery
Preoperative neoadjuvant chemoradiation therapy (NACRT) is applied for resectable pancreatic cancer (RPC). To maximize the efficacy of NACRT, it is essential to ensure the accurate placement of fiducial markers for image-guided radiation. However, no standard method for delivering fiducial markers has been established to date, and the nature of RPC during NACRT remains unclear.